“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

(TSX:BCT),(NASDAQ:BCTX),(NASDAQ:BCTXW),(NASDAQ:BCTXZ), Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers and long COVID BriaCell's Phase 3 clinical trial in metastatic breast cancer featured as “clinical trial to watch in 2026” BriaCell anticipates reporting top line data as early as […]

Cartier Reports Significant Gold Resource Growth At Cadillac With 9,953,000 tonnes at a grade of 2.40g/t Au for 767,800 Ounces Measured and Indicated, a 7% Increase and 35,185,000 tonnes at a grade of 2.14g/t Au for 2,416,900 Ounces Inferred, a 48% Increase

(TSX-V:ECR),(Boerse Frankfurt – Freiverkehr:6CA), VAL-D'OR, Quebec, Dec. 18, 2025 (GLOBE NEWSWIRE) — Cartier Resources Inc. (“Cartier” or the “Company“) (TSXV: ECR; FSE: 6CA) is pleased to announce the results of the Updated Mineral Resource Estimate (“MRE”) on its 100% owned flagship Cadillac Project, located in Val-d'Or (Abitibi, Quebec). The updated estimates include approximately 110,000 metres

Knight Therapeutics Announces Health Canada Approval for WYNZORA(R) to Treat Psoriasis Vulgaris

(TSX:GUD), MONTREAL, Dec. 18, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA(R), a white uniform cream containing 0.05 mg/g of calcipotriol (CAL) and 0.5 mg/g of betamethasone dipropionate (BDP), indicated for the topical treatment of psoriasis vulgaris in adults

Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI(R) Injector based on enFuse(R) Technology

CINCINNATI, Dec. 18, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse(R) On-Body Delivery System, today announced that the EMPAVELI(R) Injector, based on enFuse technology, has received marketing authorization from the Saudi Food and Drug Authority (SFDA). The authorization for the injector and syringe transfer system is

Terra Innovatum Global Honored with Sustainability Special Mention at 2025 UNCA Awards

(NasdaqGM:NKLR), NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Global N.V. (“Terra Innovatum” or the “Company“) (NASDAQ: NKLR), a developer of micro-modular nuclear reactors today announced that it has been honored with a Special Mention for Sustainability at the 2025 United Nations Correspondents Association (UNCA) Awards Gala. Left to Right: Cesare Frepoli –

K Wave Media Issues Corporate Update Highlighting SEC Clearance, Strategic Acquisition, and Financial Restructuring Progress

K Wave Media Issues Corporate Update Highlighting SEC Clearance, Strategic Acquisition, and Financial Restructuring Progress GlobeNewswire December 18, 2025 NEW YORK and SEOUL, South Korea, Dec. 18, 2025 (GLOBE NEWSWIRE) — K Wave Media (Nasdaq: KWM), a Korean cultural innovation and digital asset company, today provided a corporate update summarizing recent milestones and announcing a

StorageVault to Acquire Six Assets for $71.8 Million, Exceeding $200 Million Completed and Announced Transactions for 2025

StorageVault to Acquire Six Assets for $71.8 Million, Exceeding $200 Million Completed and Announced Transactions for 2025 GlobeNewswire December 18, 2025 TORONTO, Dec. 18, 2025 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault“) (SVI-TSX) is pleased to announce that it has agreed to acquire six assets from five vendor groups (collectively, the “Vendors“) for an aggregate

Domestic Metals 2025 Year End Update Grants Stock Options

Domestic Metals 2025 Year End Update Grants Stock Options GlobeNewswire December 18, 2025 VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — Domestic Metals Corp. (the “Company” or “Domestic“) – (TSXV: DMCU; OTCQB: DMCUF; FSE: 03E) provides a 2025 Year End Update. Gord Neal, CEO of Domestic Metals Corp.: “2025 was a year of team

DMG Blockchain Solutions Reports Fourth Quarter and Full Year 2025 Audited Results

DMG Blockchain Solutions Reports Fourth Quarter and Full Year 2025 Audited Results GlobeNewswire December 18, 2025 VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a vertically integrated blockchain and data center technology company, today announces its fiscal fourth quarter and full year

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer's Disease GlobeNewswire December 18, 2025 Large, well-powered Phase 1b study, designed to generate clinically and biologically meaningful insights in early Alzheimer's disease Clear and near-term value inflection points, with blinded 6-month interim data expected in Q2 2026 and final unblinded

Scroll to Top